Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study

Abstract

To evaluate systematically in real clinical settings whether functional genetic variations in drug metabolizing enzymes influence optimized doses, efficacy, and safety of antipsychotic medications